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SUMMARY OF THESIS*
BlLATE, A.M.B. - Expressão de mediadores inflamatórios e progressão diferencial de miocardite aguda e cardiomiopatia chagásica
crônica experimental em hamster sírio infectado por Trypanosoma cruzi. São Paulo, 2006. (Tese de Doutorado - Instituto de Ciências
Biomédicas da Universidade de São Paulo).
EXPRESSION OF INFLAMMATORY MEDIATORS AND DIFFERENTIAL PROGRESSION OF
ACUTE MYOCARDITIS AND CHRONIC EXPERIMENTAL CHAGASIC CARDIOMYOPATHY
IN SYRIAN HAMSTERS INFECTED WITH Trypanosoma cruzi
Chagas’ disease, caused by protozoan Trypanosoma cruzi, is a
significant cause of mortality and morbidity in many Latin-American
countries, where it is estimated that 13 million people may be infected.
Previous results from our group show that, with a single combination
of parasite (Strain Y) and genetically heterogeneous host (Syrian
hamster), it is possible to reproduce the range of different outcomes of
human Chagas’ disease. In the present study, we tested the hypothesis
that the inflammatory infiltrate and its locally produced mediators may
be related to morbidity and mortality in the acute phase and with the
severity of chronic cardiomyopathy in the Syrian hamster model of T.
cruzi infection using Strain Y. Like humans, hamsters infected by T.
cruzi Strain Y show different patterns of evolution in both the acute
and chronic phases. In the acute phase, 30-50% of animals showed
symptoms such as cachexia, lethargy, vomiting, and diarrhea, which
were related with mortality during this stage. The presence of circulating
parasites on the 13th day post-infection (PI) was associated with intense
cardiac parasitism on the date spontaneous death during the acute phase.
High cardiac parasitism, in addition to its association with symptoms,
was also associated with high expression of mRNA for IL-10, TNF-α,
and genes activated by inflammatory cytokines (A20 and iNOS) in the
myocardium. During the acute phase, blockade of TNF-α with
Etanercept lead to increased parasitism in blood and heart and to
increased expression of IL-10 in the myocardium of asymptomatic
animals. In the chronic phase of infection, although the intensity of
myocarditis was positively correlated with macroscopic dilation of the
left ventricle, none of these variables were associated with death during
the chronic phase. In this phase, there was a predominance of expression
of mRNA for IFN-γ in the myocardium over that of TNF-α and IL-10,
although the latter two were also detected at increased levels. Death
during the chronic phase was associated only with the expression of
A20. In the chronic phase, treatment with Etanercept worsened post-T.
cruzi infection chronic cardiomyopathy, as measured by ventricular
dysfunction and left ventricle dilation, and lead to increased expression
of IL-10 and decreased expression of iNOS mRNAs in the myocardium.
Overall, cardiac parasitism in the acute phase seems to determine the
levels of expression of cytokines - such as TNF-α and IFN-γ - and
genes activated by TNF-α and IFN-γ - such as iNOS. The low parasitism
and cytokines in the myocardium of asymptomatic animals suggests
that these animals were able to control parasitism before its
dissemination to the tissues during the acute phase. In the chronic
phase, although significant levels of cytokines were present in the
myocardium and the intensity local inflammation is involved in the
progression of Chagas disease cardiomyopathy to the dilated form,
these factors seem not to be determinants of mortality in chronically
infected animals. This indicates that inflammatory mechanisms play
an important pathogenic role in the evolution of T. cruzi chronic
cardiomyopathy, but are not sufficient to lead to death.
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